Epidermal Growth Factor Receptor as a Target: Recent Developments in the Search for Effective New Anti-Cancer Agents

E-ISSN： 1873-5592|2|2|117-133

ISSN： 1389-4501

Source： Current Drug Targets, Vol.2, Iss.2, 2001-06, pp. : 117-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal growth factor receptor: an important target in esophageal cancer

By Hong Liu Han Yu Brain Lubi

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 10, 2013-10 ,pp. : 1179-1185

Informa Healthcare

Access to resources Recommend Favorite

Anti-epidermal growth factor receptor drugs in cancer therapy

By Tortora Giampaolo Ciardiello Fortunato

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 755-768

Informa Healthcare

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor (EGFR) and its Cross-Talks with Topoisomerases: Challenges and Opportunities for Multi-Target Anticancer Drugs

Current Pharmaceutical Design, Vol. 22, Iss. 21, 2016-06 ,pp. : 3226-3236

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin-Like Growth Factor Receptor-1 as an Anti-Cancer Target: Blocking Transformation and Inducing Apoptosis

Current Cancer Drug Targets, Vol. 2, Iss. 3, 2002-09 ,pp. : 191-207

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors Targeted to the Epidermal Growth Factor Receptor Subfamily: Role as Anticancer Agents

By Noonberg S.B. Benz C.C.

Drugs, Vol. 59, Iss. 4, 2000-04 ,pp. : 753-767

Adis International

Access to resources Recommend Favorite